Odyssey Therapeutics Inc ODTX
$28.76 $2.36 (8.94%) 1D
Last Updated: Sep 04, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Odyssey Therapeutics Inc Stock Halal?
Shariah Compliance Analysis of ODTX Stock
United States Health Care Small Cap No. As of September 2026, Odyssey Therapeutics Inc (ODTX) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Odyssey Therapeutics Inc does not pass Musaffa's business and financial screening criteria.
Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical company which develops medicines for autoimmune and inflammatory diseases. The company is headquartered in Boston, Massachusetts and currently employs 100 full-time employees. The company went IPO on 2026-05-08. The company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its advanced programs include OD-001, an oral small-molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, and OD-002, an oral small-molecule inhibitor of solute carrier family 15 member 4, or SLC15A4. These programs have the potential to yield treatments for inflammatory and autoimmune diseases. In addition to its advanced programs, it has a portfolio of preclinical programs that include a regulatory T cell, or Treg, -specific tumor necrosis factor receptor 2, or TNFR2, agonist, a bispecific antagonist of thymic stromal lymphopoietin, or TSLP, and interleukin-33, or IL-33, and an interleukin-1 receptor-associated kinase 4, or IRAK4, scaffolding inhibitor. The company also has an interferon regulatory factor 5, or IRF5, inhibitor in preclinical development.
ODTX Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Odyssey Therapeutics Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Odyssey Therapeutics Inc (ODTX) Chart
Financial Metrics & Statements of Odyssey Therapeutics Inc (ODTX)
FAQ's for Odyssey Therapeutics Inc (ODTX)
- As of September 2026, Odyssey Therapeutics Inc ODTX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Odyssey Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Odyssey Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Odyssey Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Odyssey Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Odyssey Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Odyssey Therapeutics Inc (ODTX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
